Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Beyond Blue is an international market research firm specializing in the pharmaceutical industry. The company has their headquarter based in Manchester. Operating globally, the company is active in over thirty-five countries. Beyond Blue was founded in 2005 by Peter Heideman and his wife, which started as Blueprint Partnership. Currently, more than fifty people work for the company, distributed across three management levels: project directors at the highest level, project managers beneath them, and project executives below the managers. Additionally, there is a data analytics group.
From Development to Market
The development of a new medicine is a lengthy process. Once a pharmaceutical company has developed a new drug and passed the legal and testing stages involving (animal) trials, consideration is given to how the drug can be marketed. Beyond Blue conducts market research and subsequently provides advice on target audiences and countries that would be interesting for selling the medicine. Such projects typically take about six months to complete. The company always provides honest advice, even if the research indicates that the target audience may have less interest in the medicine or if the drug is similar to another medication.
Actionable Insights
When a pharmaceutical company intends to launch a drug into the market, a proposal is written and sent to several market research firms, such as Beyond Blue. Beyond Blue then develops a plan of action, including a budget plan, and prepares a presentation. All of this is sent to the client before the deadline. Beyond Blue waits for the client to decide which market research firm will conduct the study. If Beyond Blue gets the assignment, their task is to investigate the individuals and countries interested in the medicine. The company collaborates with field agencies in over thirty-five countries, which conduct interviews with specialists to gauge their opinions on the new drug. Sometimes as many as three hundred interviews are conducted. The results of all the interviews and additional research are analyzed, leading to actionable advice. This advice is then presented to the client. Recommendations often go beyond a simple ‘go’ or ‘no-go’ for the drug; frequently, they specify the countries and target audiences where the medicine could be successful based on the research results.
Quality Commitment
The success of Beyond Blue is attributed to the people with whom they collaborate. Everyone joining Beyond Blue possesses specific knowledge, and internal training is also provided. Quality is highly prioritized, and it takes precedence over quantity. There have been instances where the company rejected a project because there were not enough capable employees available at that time. The serious commitment to quality results in the pharmaceutical industry willingly entrusting challenging and complex projects to Beyond Blue.
